Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapy

(MedPage Today) -- CHICAGO -- Sacubitril/valsartan (Entresto) was effective at keeping cardiotoxicity at bay in high-risk people receiving anthracycline chemotherapy in the SARAH trial.
Cancer patients were less likely to have a greater than...